Ariad.info
Title
ARIAD - Signaling Pathways to Better Health
Description
Excerpted from the website:
- Pathways to Better Therapies
- Cancer patients throughout the world are in urgent need of better treatment options. At ARIAD, we believe the way to breakthrough cancer therapies for many forms of cancer is through the regulation of cell-signaling pathways. We are building a fully integrated oncology company founded on our expertise in cell-signaling and moving rapidly to advance our lead product candidate and pipeline candidates through development to the patients who need them.
Languages
English
Additional Information
Related Domains
External Links
- Alexa: Ariad.info
- WHOIS for Ariad.info
Domain Resolution
This domain resolves to the following IP addresses:
Categories:
- Ap1903
- Argent
- Anemia
- Bmt
- Bone Marrow Transplantation
- Bone Resorption
- Cancer Drug
- Conditional Knock Out
- Dimerizer
- Dimerizer Drug
- Drug Screening
- Epo
- Erythropoietin
- Functional Genomics
- Gene
- Gene Activation
- Gene Regulation
- Gene Switch
- Gene Therapy
- Graft Vs Host Disease
- Gv Hd
- Heterodimerization
- Homodimerization
- Immune Diseases
- Inducible Gene Expression
- Inducible Knock Out Mouse
- Inflammation
- Kinase Inhibitor
- Mouse
- Nf At
- Nf K B
- Nf Kappa B
- N Fk B
- Orally Active Protein Therapy
- Osteoporosis Drug
- Product Validation
- Protein Engineering
- Proteomics
- Rge
- Rpd
- Rage
- Rapamycin
- Rapid
- Regulated Cell Therapy
- Regulated Gene Therapy
- Regulated Gene Transcription
- Regulated Protein Secretion
- Regulated Signal Transduction
- Regulation Kit
- Signal Transduction
- Signal Transduction Inhibitors
- Small Molecule
- Src
- Stem Cell Therapy
- Structure Based Drug Design
- Target Validation
- Tyrosine Kinase
- Zap
- 70
- AP1903
- ARGENT
- BMT
- Conditional Knock-out
- Graft-vs-host Disease
- Graft-vs-host Disease Cell Therapy
- GvHD
- Inducible Knock-out Mouse
- NF-AT
- NF-kB
- NF-kappaB
- NFkB
- RGE
- RPD
- Structure-based Drug Design
- ZAP